[Significance of vasomotor reactions for gynecologic oncologic therapy].
Neu
E
E
Inst. f. Pharmakol., Tox. u. Pharmazie, Urol. Klinik München Grosshadern.
Michailov
M C
MC
Welscher
U
U
Tempel
K
K
Willich
N
N
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005833:Genital Neoplasms, Female / Q000098:blood supply / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D006979:Hyperthermia, Induced; D051381:Rats; D014661:Vasoconstriction / Q000187:drug effects / Q000528:radiation effects; D014666:Vasomotor System / Q000187:drug effects / Q000528:radiation effects*
D000970:Antineoplastic Agents; D001761:Bleomycin; D004317:Doxorubicin